OXAZYME Trademark

Trademark Overview

On Wednesday, May 25, 2016, a trademark application was filed for OXAZYME with the United States Patent and Trademark Office. The USPTO has given the OXAZYME trademark a serial number of 87049407. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 13, 2020. This trademark is owned by OxThera Intellectual Property AB. The OXAZYME trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical product for the treatment and prevention of kidney stones
oxazyme

General Information

Serial Number87049407
Word MarkOXAZYME
Filing DateWednesday, May 25, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 13, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 18, 2016

Trademark Statements

Goods and ServicesPharmaceutical product for the treatment and prevention of kidney stones

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 1, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOxThera Intellectual Property AB
Party Type20 - Owner at Publication
Legal Entity Type11 - Company
AddressS114 36 Stockholm S11436
SE
Party NameOxThera Intellectual Property AB
Party Type10 - Original Applicant
Legal Entity Type11 - Company
AddressS114 36 Stockholm
SE

Trademark Events

Event DateEvent Description
Monday, January 13, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 13, 2020ABANDONMENT - NO USE STATEMENT FILED
Thursday, June 6, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 5, 2019EXTENSION 5 GRANTED
Monday, June 3, 2019EXTENSION 5 FILED
Wednesday, June 5, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, June 3, 2019TEAS EXTENSION RECEIVED
Thursday, November 22, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 20, 2018EXTENSION 4 GRANTED
Tuesday, November 20, 2018EXTENSION 4 FILED
Tuesday, November 20, 2018TEAS EXTENSION RECEIVED
Thursday, June 7, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 5, 2018EXTENSION 3 GRANTED
Tuesday, June 5, 2018EXTENSION 3 FILED
Tuesday, June 5, 2018TEAS EXTENSION RECEIVED
Wednesday, December 13, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 11, 2017EXTENSION 2 GRANTED
Monday, December 11, 2017EXTENSION 2 FILED
Monday, December 11, 2017TEAS EXTENSION RECEIVED
Thursday, June 15, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 13, 2017EXTENSION 1 GRANTED
Tuesday, June 13, 2017EXTENSION 1 FILED
Tuesday, June 13, 2017TEAS EXTENSION RECEIVED
Tuesday, December 13, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 18, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 18, 2016PUBLISHED FOR OPPOSITION
Wednesday, September 28, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, September 10, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 9, 2016ASSIGNED TO EXAMINER
Wednesday, June 1, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, May 28, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

oxazyme kidney stones prevention treatment product pharmaceutical